전체메뉴 닫기

항상 최고의 진료를
약속합니다

산부인과(부인종양센터) 윤보성 교수

일반진료
오전 진료 진료 진료 진료 1,3,5주
오후 진료

전문분야

부인암, 부인종양(자궁근종, 선근증, 난소종양, 자궁내막증), 단일공수술, 로봇수술, 복강경수술, 자궁경수술, 비정상자궁경부세포

교수 경력

  • 연세대학교
  • 차의과학대학교

진료 경력

  • 연세대학교 신촌세브란스병원 산부인과
  • 차의과학대학교 강남차병원 산부인과
  • 차의과학대학교 일산차병원 산부인과
  • 차의과학대학교 일산차병원 부인종양센터

학회·연구·연수·수상 경력

  • 미국 Yale University 부인종양학 연수
  • 대한부인종양학회 수련위원회 위원

  • 언론기사·영상
  • 논문
  1. Predictive factor for volume reduction of uterine fibroids after short-term use of ulipristal acetate. Eur J Obstet Gynecol Reprod Biol. 2018 May;224:133-136.
  2. Therapeutic outcomes of methotrexate injection in unruptured interstitial pregnancy. Obstet Gynecol Sci. 2017 Nov;60(6):571-578.
  3. Effect of menstrual phase on the surgical treatment of ovarian cysts. J Obstet Gynaecol. 2017 Oct;37(7):919-923.
  4. Minimally invasive compared with open surgery in patients with borderline ovarian tumors. Gynecol Oncol. 2017 Jun;145(3):508-512.
  5. Combined Oral Medroxyprogesterone/Levonorgestrel-Intrauterine System Treatment for Women With Grade 2 Stage IA Endometrial Cancer. Int J Gynecol Cancer. 2017 May;27(4):738-742.
  6. Uterine fibroid shrinkage after short-term use of selective progesterone receptor modulator or gonadotropin-releasing hormone agonist. Obstet Gynecol Sci. 2017 Jan;60(1):69-73.
  7. Dilatation and curettage is more accurate than endometrial aspiration biopsy in early-stage endometrial cancer patients treated with high dose oral progestin and levonorgestrel intrauterine system. J Gynecol Oncol. 2016 Aug 2:e1.
  8. Redefining the origin and evolution of ovarian cancer: a hormonal connection. Endocr Relat Cancer. 2016 Sep;23(9):R411-22.
  9. The efficacy of long-term maintenance therapy with a levonorgestrel-releasing intrauterine system for prevention of ovarian endometrioma recurrence. Int J Gynaecol Obstet. 2016 Sep;134(3):256-9.
  10. Impact of opportunistic salpingectomy on anti-Müllerian hormone in patients undergoing laparoscopic hysterectomy: a multicentre randomised controlled trial. BJOG. 2017 Jan;124(2):314-320.
  11. The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) on cancer recurrence and survival: a meta-analysis. Eur J Cancer Prev. 2017 Jan;26(1):78-85.
  12. Single-dose versus two-dose administration of methotrexate for the treatment of ectopic pregnancy: a randomized controlled trial. Hum Reprod. 2016 Feb;31(2):332-8.
  13. Use of vasopressin vs epinephrine to reduce haemorrhage during myomectomy: a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2015 Dec;195:177-81.
  14. Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis. Taiwan J Obstet Gynecol. 2015 Aug;54(4):412-5.
  15. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist. Eur J Obstet Gynecol Reprod Biol. 2015 Aug;191:62-7.
  16. A Randomized Comparison of Laparoendoscopic Single-Site Hysterectomies: Total Laparoscopic Hysterectomy Versus Laparoscopically Assisted Vaginal Hysterectomy. J Laparoendosc Adv Surg Tech A. 2015 Jul;25(7):541-7.
  17. Operative outcomes of single-port-access laparoscopy-assisted vaginal hysterectomy compared with single-port-access total laparoscopic hysterectomy. Taiwan J Obstet Gynecol. 2014 Dec;53(4):486-9.
  18. Laparoscopic salpingotomy using the floseal hemostatic sealant in patients with tubal pregnancy. J Laparoendosc Adv Surg Tech A. 2014 Sep;24(9):651-5.
  19. Effectiveness of different routes of misoprostol administration before operative hysteroscopy: a randomized, controlled trial. Fertil Steril. 2014 Aug;102(2):519-24.
  20. Is myomectomy in women aged 45 years and older an effective option? Eur J Obstet Gynecol Reprod Biol. 2014 Jun;177:57-60.
  21. Impact on ovarian reserve after laparoscopic ovarian cystectomy with reduced port number: a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2014 May;176:34-8.
  22. Risk factors for treatment failure of CO2 laser vaporization in cervical intraepithelial neoplasia 2. Arch Gynecol Obstet. 2014 Jul;290(1):115-9.
  23. Laparoendoscopic single-site versus conventional laparoscopic gynecologic surgery: a metaanalysis of randomized controlled trials. Am J Obstet Gynecol. 2013 Oct;209(4):317.e1-9.
  24. Would fewer port numbers in laparoscopy produce better cosmesis? Prospective study. J Minim Invasive Gynecol. 2014 Jan-Feb;21(1):68-73.
  25. Comparison of dilatation & curettage and endometrial aspiration biopsy accuracy in patients treated with high-dose oral progestin plus levonorgestrel intrauterine system for early-stage endometrial cancer. Gynecol Oncol. 2013 Sep;130(3):470-3.
  26. Combined medroxyprogesterone acetate/levonorgestrel-intrauterine system treatment in young women with early-stage endometrial cancer. Am J Obstet Gynecol. 2013 Oct;209(4):358.e1-4.
  27. Comparison of single-port, two-port and four-port laparoscopic surgery for cyst enucleation in benign ovarian cysts. Gynecol Obstet Invest. 2013;76(1):57-63.
  28. Single-port access total laparoscopic hysterectomy for large uterus. Gynecol Obstet Invest. 2013;75(1):16-20.
  29. Intraoperative intraperitoneal chemotherapy with cisplatin in epithelial ovarian cancer. J Gynecol Oncol. 2012 Apr;23(2):91-7.
  30. Single-port versus conventional laparoscopic salpingectomy in tubal pregnancy: a comparison of surgical outcomes. Eur J Obstet Gynecol Reprod Biol. 2011 Nov;159(1):190-3.
  31. Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium. Arch Gynecol Obstet. 2012 Feb;285(2):473-8.
  32. Can misoprostol reduce blood loss in laparoscopy-assisted vaginal hysterectomy? Aust N Z J Obstet Gynaecol. 2011 Jun;51(3):248-51.
  33. Conservative treatment with medroxyprogesterone acetate plus levonorgestrel intrauterine system for early-stage endometrial cancer in young women: pilot study. Int J Gynecol Cancer. 2011 May;21(4):673-7.
  34. Rapid recurrence of uterine smooth muscle tumor of uncertain malignant potential as leiomyosarcoma. Int J Gynaecol Obstet. 2011 Jun;113(3):244-5.
  35. Spontaneous vaginal expulsion of uterine myoma after magnetic resonance-guided focused ultrasound surgery. J Minim Invasive Gynecol. 2011 Jan-Feb;18(1):131-4.
  36. Short-term results of magnetic resonance imaging-guided focused ultrasound surgery for patients with adenomyosis: symptomatic relief and pain reduction. Fertil Steril. 2011 Mar 1;95(3):1152-5.
  37. The effectiveness of levonorgestrel releasing intrauterine system in the treatment of endometrial hyperplasia in Korean women. J Gynecol Oncol. 2010 Jun;21(2):102-5.
  38. Cellular fibroma of the ovary containing Leydig cell hyperplasia: a case report. J Gynecol Oncol. 2010 Mar;21(1):56-8.
  39. Single-port laparoscopic salpingectomy for the surgical treatment of ectopic pregnancy. J Minim Invasive Gynecol. 2010 Jan-Feb;17(1):26-9.
  40. Clinical significance of microsatellite instability in sporadic epithelial ovarian tumors. Yonsei Med J. 2008 Apr 30;49(2):272-8.
  41. NM23 as a prognostic biomarker in ovarian serous carcinoma. Mod Pathol. 2008 Jul;21(7):885-92.
  42. Prognostic value of nuclear DNA quantification and cyclin A expression in epithelial ovarian carcinoma. Eur J Obstet Gynecol Reprod Biol. 2008 Jan;136(1):110-5.
  43. Expression of human leukocyte antigen-G and its correlation with interleukin-10 expression in cervical carcinoma. Int J Gynaecol Obstet. 2007 Jul;98(1):48-53.
  44. An ovarian steroid cell tumor causing virilization and massive ascites. Yonsei Med J. 2007 Feb 28;48(1):142-6.
  45. Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy. Gynecol Oncol. 2007 Apr;105(1):199-204.
  46. Analysis of chromosomal changes in serous ovarian carcinoma using high-resolution array comparative genomic hybridization: Potential predictive markers of chemoresistant disease. Genes Chromosomes Cancer. 2007 Jan;46(1):1-9.
  47. Prognostic factors and expression of p53 and mdm-2 in uterine sarcomas. Int J Gynaecol Obstet. 2006 Dec;95(3):272-7.
  48. Expression profiling of cyclin B1 and D1 in cervical carcinoma. Exp Oncol. 2006 Mar;28(1):44-8.
  49. Expression of c-erbB-2 oncoprotein and the prognosis of patients with cervical carcinoma. Int J Gynaecol Obstet. 2006 Feb;92(2):151-2.
  50. Germline mutations of BRCA1 and BRCA2 in Korean sporadic ovarian carcinoma. Gynecol Oncol. 2005 Dec;99(3):585-90.
  51. Pretreatment levels of serum squamous cell carcinoma antigen and urine polyamines in women with squamous cell carcinoma of the cervix. Int J Gynaecol Obstet. 2005 Oct;91(1):47-52
  52. Clinical usefulness of cervicogram as a primary screening test for cervical neoplasia. Yonsei Med J. 2005 Apr 30;46(2):213-20.
  53. Survey of the characteristics and satisfaction degree of the patients using a pessary. Int Urogynecol J Pelvic Floor Dysfunct. 2005 May-Jun;16(3):182-6; discussion 186.